The global market for Antiviral Drug Packaging was estimated to be worth US$ 26500 million in 2023 and is forecast to a readjusted size of US$ 34130 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030

Antiviral Drug Packaging - Market

Antiviral drug packaging is specially designed for packaging antiviral drugs. Antiviral drugs are a class of medication used specifically for treating viral infections such as influenza, herpes virus infections, viral hepatitis and human immunodeficiency virus.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antiviral Drug Packaging, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antiviral Drug Packaging by region & country, by Type, and by Application.

The Antiviral Drug Packaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Drug Packaging.

Market Segmentation

Scope of Antiviral Drug Packaging - Market Report

Report Metric	Details
Report Name	Antiviral Drug Packaging - Market
Forecasted market size in 2030	US$ 34130 million
CAGR	3.7%
Forecasted years	2024 - 2030
Segment by Type:	Rigid Plastic Flexible Blister Foils Others
Segment by Application	Pharmaceuticals Healthcare
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF, Lonza, Takex Labo Co. Ltd, Berry, Lageen Tubes.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antiviral Drug Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antiviral Drug Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antiviral Drug Packaging in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Antiviral Drug Packaging - Market size in 2030?

Ans: The Antiviral Drug Packaging - Market size in 2030 will be US$ 34130 million.

Who are the main players in the Antiviral Drug Packaging - Market report?

Ans: The main players in the Antiviral Drug Packaging - Market are Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF, Lonza, Takex Labo Co. Ltd, Berry, Lageen Tubes.

What are the Application segmentation covered in the Antiviral Drug Packaging - Market report?

Ans: The Applications covered in the Antiviral Drug Packaging - Market report are Pharmaceuticals, Healthcare

What are the Type segmentation covered in the Antiviral Drug Packaging - Market report?

Ans: The Types covered in the Antiviral Drug Packaging - Market report are Rigid Plastic, Flexible Blister Foils, Others

1 Market Overview

1.1 Antiviral Drug Packaging Product Introduction

1.2 Global Antiviral Drug Packaging Market Size Forecast

1.2.1 Global Antiviral Drug Packaging Sales Value (2019-2030)

1.2.2 Global Antiviral Drug Packaging Sales Volume (2019-2030)

1.2.3 Global Antiviral Drug Packaging Sales Price (2019-2030)

1.3 Antiviral Drug Packaging Market Trends & Drivers

1.3.1 Antiviral Drug Packaging Industry Trends

1.3.2 Antiviral Drug Packaging Market Drivers & Opportunity

1.3.3 Antiviral Drug Packaging Market Challenges

1.3.4 Antiviral Drug Packaging Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Antiviral Drug Packaging Players Revenue Ranking (2023)

2.2 Global Antiviral Drug Packaging Revenue by Company (2019-2024)

2.3 Global Antiviral Drug Packaging Players Sales Volume Ranking (2023)

2.4 Global Antiviral Drug Packaging Sales Volume by Company Players (2019-2024)

2.5 Global Antiviral Drug Packaging Average Price by Company (2019-2024)

2.6 Key Manufacturers Antiviral Drug Packaging Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Antiviral Drug Packaging Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Antiviral Drug Packaging

2.9 Antiviral Drug Packaging Market Competitive Analysis

2.9.1 Antiviral Drug Packaging Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Antiviral Drug Packaging Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Packaging as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Rigid Plastic

3.1.2 Flexible Blister Foils

3.1.3 Others

3.2 Global Antiviral Drug Packaging Sales Value by Type

3.2.1 Global Antiviral Drug Packaging Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Antiviral Drug Packaging Sales Value, by Type (2019-2030)

3.2.3 Global Antiviral Drug Packaging Sales Value, by Type (%) (2019-2030)

3.3 Global Antiviral Drug Packaging Sales Volume by Type

3.3.1 Global Antiviral Drug Packaging Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Antiviral Drug Packaging Sales Volume, by Type (2019-2030)

3.3.3 Global Antiviral Drug Packaging Sales Volume, by Type (%) (2019-2030)

3.4 Global Antiviral Drug Packaging Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pharmaceuticals

4.1.2 Healthcare

4.2 Global Antiviral Drug Packaging Sales Value by Application

4.2.1 Global Antiviral Drug Packaging Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Antiviral Drug Packaging Sales Value, by Application (2019-2030)

4.2.3 Global Antiviral Drug Packaging Sales Value, by Application (%) (2019-2030)

4.3 Global Antiviral Drug Packaging Sales Volume by Application

4.3.1 Global Antiviral Drug Packaging Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Antiviral Drug Packaging Sales Volume, by Application (2019-2030)

4.3.3 Global Antiviral Drug Packaging Sales Volume, by Application (%) (2019-2030)

4.4 Global Antiviral Drug Packaging Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Antiviral Drug Packaging Sales Value by Region

5.1.1 Global Antiviral Drug Packaging Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Antiviral Drug Packaging Sales Value by Region (2019-2024)

5.1.3 Global Antiviral Drug Packaging Sales Value by Region (2025-2030)

5.1.4 Global Antiviral Drug Packaging Sales Value by Region (%), (2019-2030)

5.2 Global Antiviral Drug Packaging Sales Volume by Region

5.2.1 Global Antiviral Drug Packaging Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Antiviral Drug Packaging Sales Volume by Region (2019-2024)

5.2.3 Global Antiviral Drug Packaging Sales Volume by Region (2025-2030)

5.2.4 Global Antiviral Drug Packaging Sales Volume by Region (%), (2019-2030)

5.3 Global Antiviral Drug Packaging Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Antiviral Drug Packaging Sales Value, 2019-2030

5.4.2 North America Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Antiviral Drug Packaging Sales Value, 2019-2030

5.5.2 Europe Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Antiviral Drug Packaging Sales Value, 2019-2030

5.6.2 Asia Pacific Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Antiviral Drug Packaging Sales Value, 2019-2030

5.7.2 South America Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Antiviral Drug Packaging Sales Value, 2019-2030

5.8.2 Middle East & Africa Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Antiviral Drug Packaging Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Antiviral Drug Packaging Sales Value

6.2.1 Key Countries/Regions Antiviral Drug Packaging Sales Value, 2019-2030

6.2.2 Key Countries/Regions Antiviral Drug Packaging Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Antiviral Drug Packaging Sales Value, 2019-2030

6.3.2 United States Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Antiviral Drug Packaging Sales Value, 2019-2030

6.4.2 Europe Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Antiviral Drug Packaging Sales Value, 2019-2030

6.5.2 China Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

6.5.3 China Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Antiviral Drug Packaging Sales Value, 2019-2030

6.6.2 Japan Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Antiviral Drug Packaging Sales Value, 2019-2030

6.7.2 South Korea Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Antiviral Drug Packaging Sales Value, 2019-2030

6.8.2 Southeast Asia Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Antiviral Drug Packaging Sales Value, 2019-2030

6.9.2 India Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

6.9.3 India Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Avery Dennison Corporation

7.1.1 Avery Dennison Corporation Company Information

7.1.2 Avery Dennison Corporation Introduction and Business Overview

7.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Avery Dennison Corporation Antiviral Drug Packaging Product Offerings

7.1.5 Avery Dennison Corporation Recent Development

7.2 E.I. du Pont de Nemours

7.2.1 E.I. du Pont de Nemours Company Information

7.2.2 E.I. du Pont de Nemours Introduction and Business Overview

7.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.2.4 E.I. du Pont de Nemours Antiviral Drug Packaging Product Offerings

7.2.5 E.I. du Pont de Nemours Recent Development

7.3 CCL Industries Inc

7.3.1 CCL Industries Inc Company Information

7.3.2 CCL Industries Inc Introduction and Business Overview

7.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.3.4 CCL Industries Inc Antiviral Drug Packaging Product Offerings

7.3.5 CCL Industries Inc Recent Development

7.4 BioCote

7.4.1 BioCote Company Information

7.4.2 BioCote Introduction and Business Overview

7.4.3 BioCote Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.4.4 BioCote Antiviral Drug Packaging Product Offerings

7.4.5 BioCote Recent Development

7.5 Avient

7.5.1 Avient Company Information

7.5.2 Avient Introduction and Business Overview

7.5.3 Avient Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Avient Antiviral Drug Packaging Product Offerings

7.5.5 Avient Recent Development

7.6 Mondi

7.6.1 Mondi Company Information

7.6.2 Mondi Introduction and Business Overview

7.6.3 Mondi Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Mondi Antiviral Drug Packaging Product Offerings

7.6.5 Mondi Recent Development

7.7 Biomaster

7.7.1 Biomaster Company Information

7.7.2 Biomaster Introduction and Business Overview

7.7.3 Biomaster Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Biomaster Antiviral Drug Packaging Product Offerings

7.7.5 Biomaster Recent Development

7.8 BASF

7.8.1 BASF Company Information

7.8.2 BASF Introduction and Business Overview

7.8.3 BASF Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.8.4 BASF Antiviral Drug Packaging Product Offerings

7.8.5 BASF Recent Development

7.9 Lonza

7.9.1 Lonza Company Information

7.9.2 Lonza Introduction and Business Overview

7.9.3 Lonza Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Lonza Antiviral Drug Packaging Product Offerings

7.9.5 Lonza Recent Development

7.10 Takex Labo Co. Ltd

7.10.1 Takex Labo Co. Ltd Company Information

7.10.2 Takex Labo Co. Ltd Introduction and Business Overview

7.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Takex Labo Co. Ltd Antiviral Drug Packaging Product Offerings

7.10.5 Takex Labo Co. Ltd Recent Development

7.11 Berry

7.11.1 Berry Company Information

7.11.2 Berry Introduction and Business Overview

7.11.3 Berry Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Berry Antiviral Drug Packaging Product Offerings

7.11.5 Berry Recent Development

7.12 Lageen Tubes.

7.12.1 Lageen Tubes. Company Information

7.12.2 Lageen Tubes. Introduction and Business Overview

7.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Lageen Tubes. Antiviral Drug Packaging Product Offerings

7.12.5 Lageen Tubes. Recent Development

8 Industry Chain Analysis

8.1 Antiviral Drug Packaging Industrial Chain

8.2 Antiviral Drug Packaging Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Antiviral Drug Packaging Sales Model

8.5.2 Sales Channel

8.5.3 Antiviral Drug Packaging Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Avery Dennison Corporation

E.I. du Pont de Nemours

List of Tables

Table 1. Antiviral Drug Packaging Market Trends

Table 2. Antiviral Drug Packaging Market Drivers & Opportunity

Table 3. Antiviral Drug Packaging Market Challenges

Table 4. Antiviral Drug Packaging Market Restraints

Table 5. Global Antiviral Drug Packaging Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Antiviral Drug Packaging Revenue Market Share by Company (2019-2024)

Table 7. Global Antiviral Drug Packaging Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Antiviral Drug Packaging Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Antiviral Drug Packaging Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Antiviral Drug Packaging Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Antiviral Drug Packaging Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Antiviral Drug Packaging

Table 13. Global Antiviral Drug Packaging Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Packaging as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Antiviral Drug Packaging Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Antiviral Drug Packaging Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Antiviral Drug Packaging Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Antiviral Drug Packaging Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Antiviral Drug Packaging Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Antiviral Drug Packaging Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Antiviral Drug Packaging Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Antiviral Drug Packaging Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Antiviral Drug Packaging Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Antiviral Drug Packaging Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Antiviral Drug Packaging Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Antiviral Drug Packaging Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Antiviral Drug Packaging Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Antiviral Drug Packaging Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Antiviral Drug Packaging Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Antiviral Drug Packaging Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Antiviral Drug Packaging Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Antiviral Drug Packaging Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Antiviral Drug Packaging Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Antiviral Drug Packaging Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Antiviral Drug Packaging Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Antiviral Drug Packaging Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Antiviral Drug Packaging Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Antiviral Drug Packaging Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Antiviral Drug Packaging Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Antiviral Drug Packaging Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Antiviral Drug Packaging Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Antiviral Drug Packaging Sales Value by Region (2019-2024) & (%)

Table 44. Global Antiviral Drug Packaging Sales Value by Region (2025-2030) & (%)

Table 45. Global Antiviral Drug Packaging Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Antiviral Drug Packaging Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Antiviral Drug Packaging Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Antiviral Drug Packaging Sales Volume by Region (2019-2024) & (%)

Table 49. Global Antiviral Drug Packaging Sales Volume by Region (2025-2030) & (%)

Table 50. Global Antiviral Drug Packaging Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Antiviral Drug Packaging Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Antiviral Drug Packaging Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Antiviral Drug Packaging Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Antiviral Drug Packaging Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Antiviral Drug Packaging Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Antiviral Drug Packaging Sales Volume, (2025-2030) & (K Units)

Table 57. Avery Dennison Corporation Company Information

Table 58. Avery Dennison Corporation Introduction and Business Overview

Table 59. Avery Dennison Corporation Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Avery Dennison Corporation Antiviral Drug Packaging Product Offerings

Table 61. Avery Dennison Corporation Recent Development

Table 62. E.I. du Pont de Nemours Company Information

Table 63. E.I. du Pont de Nemours Introduction and Business Overview

Table 64. E.I. du Pont de Nemours Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. E.I. du Pont de Nemours Antiviral Drug Packaging Product Offerings

Table 66. E.I. du Pont de Nemours Recent Development

Table 67. CCL Industries Inc Company Information

Table 68. CCL Industries Inc Introduction and Business Overview

Table 69. CCL Industries Inc Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. CCL Industries Inc Antiviral Drug Packaging Product Offerings

Table 71. CCL Industries Inc Recent Development

Table 72. BioCote Company Information

Table 73. BioCote Introduction and Business Overview

Table 74. BioCote Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. BioCote Antiviral Drug Packaging Product Offerings

Table 76. BioCote Recent Development

Table 77. Avient Company Information

Table 78. Avient Introduction and Business Overview

Table 79. Avient Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Avient Antiviral Drug Packaging Product Offerings

Table 81. Avient Recent Development

Table 82. Mondi Company Information

Table 83. Mondi Introduction and Business Overview

Table 84. Mondi Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Mondi Antiviral Drug Packaging Product Offerings

Table 86. Mondi Recent Development

Table 87. Biomaster Company Information

Table 88. Biomaster Introduction and Business Overview

Table 89. Biomaster Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Biomaster Antiviral Drug Packaging Product Offerings

Table 91. Biomaster Recent Development

Table 92. BASF Company Information

Table 93. BASF Introduction and Business Overview

Table 94. BASF Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. BASF Antiviral Drug Packaging Product Offerings

Table 96. BASF Recent Development

Table 97. Lonza Company Information

Table 98. Lonza Introduction and Business Overview

Table 99. Lonza Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Lonza Antiviral Drug Packaging Product Offerings

Table 101. Lonza Recent Development

Table 102. Takex Labo Co. Ltd Company Information

Table 103. Takex Labo Co. Ltd Introduction and Business Overview

Table 104. Takex Labo Co. Ltd Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Takex Labo Co. Ltd Antiviral Drug Packaging Product Offerings

Table 106. Takex Labo Co. Ltd Recent Development

Table 107. Berry Company Information

Table 108. Berry Introduction and Business Overview

Table 109. Berry Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Berry Antiviral Drug Packaging Product Offerings

Table 111. Berry Recent Development

Table 112. Lageen Tubes. Company Information

Table 113. Lageen Tubes. Introduction and Business Overview

Table 114. Lageen Tubes. Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Lageen Tubes. Antiviral Drug Packaging Product Offerings

Table 116. Lageen Tubes. Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Antiviral Drug Packaging Downstream Customers

Table 120. Antiviral Drug Packaging Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Antiviral Drug Packaging Product Picture

Figure 2. Global Antiviral Drug Packaging Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Antiviral Drug Packaging Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Antiviral Drug Packaging Sales Volume (2019-2030) & (K Units)

Figure 5. Global Antiviral Drug Packaging Sales Price (2019-2030) & (US$/Unit)

Figure 6. Antiviral Drug Packaging Report Years Considered

Figure 7. Global Antiviral Drug Packaging Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Antiviral Drug Packaging Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiviral Drug Packaging Revenue in 2023

Figure 10. Antiviral Drug Packaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Rigid Plastic Picture

Figure 12. Flexible Blister Foils Picture

Figure 13. Others Picture

Figure 14. Global Antiviral Drug Packaging Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Antiviral Drug Packaging Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Antiviral Drug Packaging Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Antiviral Drug Packaging Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Antiviral Drug Packaging Price by Type (2019-2030) & (US$/Unit)

Figure 19. Product Picture of Pharmaceuticals

Figure 20. Product Picture of Healthcare

Figure 21. Global Antiviral Drug Packaging Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Antiviral Drug Packaging Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Antiviral Drug Packaging Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Antiviral Drug Packaging Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Antiviral Drug Packaging Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Antiviral Drug Packaging Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Antiviral Drug Packaging Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Antiviral Drug Packaging Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Antiviral Drug Packaging Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Antiviral Drug Packaging Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Antiviral Drug Packaging Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Antiviral Drug Packaging Sales Volume (%), (2019-2030)

Figure 38. United States Antiviral Drug Packaging Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Antiviral Drug Packaging Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Antiviral Drug Packaging Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Antiviral Drug Packaging Sales Value by Application (%), 2023 VS 2030

Figure 44. China Antiviral Drug Packaging Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

Figure 46. China Antiviral Drug Packaging Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Antiviral Drug Packaging Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Antiviral Drug Packaging Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Antiviral Drug Packaging Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Antiviral Drug Packaging Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Antiviral Drug Packaging Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Antiviral Drug Packaging Sales Value by Application (%), 2023 VS 2030

Figure 56. India Antiviral Drug Packaging Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030

Figure 58. India Antiviral Drug Packaging Sales Value by Application (%), 2023 VS 2030

Figure 59. Antiviral Drug Packaging Industrial Chain

Figure 60. Antiviral Drug Packaging Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions